locus split antigens B38 (B16.1) and B39 (B16.2) allowed localization of their subtypic as well as their public specificities HLA-Bw4 or -Bw6 to the c~-helical region of the c~ 1 domain flanked by the amino acid positions 74-83. Comparison of their amino acid sequences with those of other HLA-B-locus alleles established HLA-Bw6 to be distinguished by Ser at residue 77 and Asn at residue 80. In contrast, HLA-Bw4 is characterized by at least seven different patterns of amino acid exchanges at positions 77 and 80-83. Reactivity patterns of Bw4-or Bw6-specific monoclonal antibodies reveal two alloantigenic epitopes contributing to the HLA-Bw4 or -Bw6 specificity residing next to the region of highest diversity of the cr domain.
Introduction
HLA class I antigens are polymorphic membrane glycoproteins with ubiquitous distribution on almost all nucleated cells. They bind peptides of processed antigens and present them to cytotoxic T lymphocytes (CTL; Germain 1986, Chen and . Initially, class I antigens controlled by the HLA-A, B, C loci were differentiated by the reactivity patterns mainly of pregnancy alloantisera with individual cells. Development and use of specific monoclonal antibodies, as well as T-cell responses and biochemical analyses, revealed extensive structural heterogeneity of these molecules. HLA-A, B, C antigens were thus shown to express a variety of different antigenic determinants. Like the antigens of the H-2 system in the mouse (summarized in Klein 1986 ), some of the HLA antigens are unique and define particular HLA alleles as so-called private specificities, whereas others are termed supertypic or public specificities because they are shared by several allelic products of a single locus or even by molecules encoded by different HLA loci. The earliest known supertypic HLA determinants were the HLA-Bw4 and -Bw6 specificities (van Rood 1962) . Either of them is expressed together with a particular private specificity on a given HLA-B molecule (Ayres and Cresswell 1976) . While the HLA-Bw4 determinant is found in addition on the HLA-A-locus antigens A24, A23, and A32 (Kostyu et al. 1980) , the HLA-Bw6 public specificity is also present on the product of the HLA-C-locus allele Cw3 (Layet et al. 1985) . Molecular variants of the Bw4 specificity have been reported based on the serological reactivity patterns of different Bw4-specific monoclonal antibodies (Miiller et al. 1985a , Miiller et al. 1982 . Recent cloning and sequencing of a number of different HLA alleles , as well as determination of the X-ray crystallographic structure of the HLA-A2 antigen (Bjorkman et al. 1987) , has facilitated localization of various alloantigenic epitopes detected by monoclonal antibodies or recognized by CTL. Comparison of the primary structure of HLA-B and -A molecules (Wan et al. 1986) , as well as exon shuffling experiments with and -B2 7 genes (Toubert et al. 1988) , recently suggested that the Bw4 and Bw6 specificities map to the first external domain, in particular to the amino acid residues 79-83. To characterize further genetic and structural heterogeneity of Bw4 and Bw6, we have exploited their association with the HLA-B antigens B38 and B39 which as subtypes of the HLA-B16 antigen are highly cross-reactive, but differ in the expression of these supertypic specificities.
Probes. HLA-B genes were isolated by using HLA-A and -B locusspecific probes derived from the HLA-B7 cDNA and the HLA-A2 gene as described by Koller and co-workers (Koller et al. 1984) . The HLA-B27 (Weiss et al. 1985) and -B51 genes (Pohla et al. 1989 ) have been described previously. The HLA-Cw3 gene (Sodoyer et al. 1984 ) was a gift ofB. R. Jordan (CNRS, Marseille, France). The HLA-A2 and -B7 genes (Barbosa et al. 1982) , as well as the HLA-B7 cDNA probe (Sood et al. 1981) , were kindly provided by S. Weissman (Yale University, New Haven, Connecticut).
DNA analysis. DNA extraction, restriction endonuclease mapping, and Southern blot hybridizations using specific 32p multiprimed labeled probes under highly stringent conditions were carried out according to the procedures described earlier (Williams et al. 1987, Feinberg and Vogelstein 1983) .
Isolation ofgenomic clones. Genomic DNA extracted from lymphocytes of donor S and Z was completely digested with Eco RI and electrophoresed on a preparative 0.7 % agarose gel. DNA fragments (6 kbp long) eluted from the gels were cloned in the Eco RI site of lambda gtl 1 (Promega, Madison, Wisconsin) as described previously (Williams et al. 1987) . The two independent partial genomic libraries were screened by hybridization with HLA-B7 cDNA and HLA-A or -B locus-specific probes under highly stringent conditions. Positive clones hybridizing with HLA-B7 cDNA and the HLA-B locus-specific probe were plaque purified.
Tran~fection of cloned genes. Cloned HLA genes were cotransfected with the thymidine kinase gene into mouse L(tk-) ceils by the calcium phosphate precipitation method as described earlier (Wigler et al. 1979) . As controls, L(tk-) cells were transfected with the thymidine kinase gene only. After selection in HAT medium (DMEM supplemented with 15 Ixg/ml hypoxanthine, 1 I.tg/ml aminopterin, and 5 Ixg/ml thymidine), colonies were picked and grown in mass culture. lmmunofluorescence analysis. Indirect immunofluorescence labeling of PBL and transfectants was performed with the use of poly-and monomorphic monoclonal HLA-specific antibodies and evaluated on fluorescence-activated cell sorter (FACS) IV as previously described (MOiler et al. 1985b ).
Radioimmunoassay. Surface HLA expression of transfectants was analyzed by a quantitative radioimmunoassay using the monomorphic monoclonal antibodies W6/32.HL and 4E, as well as the polymorphic monoclonal antibodies TIJ109 and 2BC4 as reported earlier (Schmidt et al. 1987) .
Isoelectricfocusing (IEF) analysis. Isoelectric focusing was carried out on HLA class I products immunoprecipitated with the monoclonal antibodies W6/32.HL or 4E from 35S-labeled transfectants and PBL of donor S and Z according to the procedure described previously (Yang et al. 1984 , Yang 1989 . PBL were stimulated with phytohemagglutinin overnight, transfectants with mouse interferon for 24 h before labeling.
DNA sequencing. After restriction endonuclease mapping of recombinant clones, subcloning of appropriate fragments up to about 500 bp was performed into pUC13. Supercoil DNA sequencing according to Chen and Seeburg (1985) was carried out by the dideoxy chain termination method (Sanger et al. 1977) and HLA-Bw39(Bw6) genes were obtained from partial genomic libraries of two German Caucasian individuals who were serologically typed heterozygous for the supertypic determinants Bw4/Bw6. IEF analysis of immunoprecipitated HLA class I antigens and comparison with previously established band patterns of HLA-A, -B, -C allelic products (Yang 1989) 
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HLA-B58 ( as B-cell lines with serologically and immunochemically well-characterized HLA class I antigens, were analyzed for their reactivity with various Bw4-and Bw6-specific monoclonal antibodies (Table 2) . Comparison of available protein sequence data with binding..patterns of monoclonal reagents revealed that the mAb TU48 (M~iller et al. 1982) reacted with all tested cells expressing the HLA-Bw4 determinant. Sequence variability in positions 77 and 80-82 appeared to correlate with variability in binding activity of T(J48. However, the mAb T(Jl09 (Mfiller et al. 1985a ) only recognized Bw4 + HLA-B antigens except B44.1. This antibody did not react with HLA-A molecules in spite of shared amino acid sequences at positions 77 and 80-83. The Bw6-specific antibody 2BC4 (Kandzia et al. 1981) reacted only with the transfected cell lines expressing Bw6 + HLA-B molecules, whereas the antibody SFR8-B6 (Radka et al. 1982 ) also recognized HLA-Cw3.
Discussion
Primary structure of the HLA-B split antigens B38 and B39 was determined to identify the amino acid substitutions responsible for the Bw4 and Bw6 specificities. HLA-B38 and -B39 are serologically difficult to distinguish by their private epitopes, but are clearly dissimilar in the Bw4 determinants. Previous comparison of HLA sequences , Wan et al. 1986 ) and exon shuffling experiments (Toubert et al. t988 ) suggested positions 79-83 of the c~l domain to generate the Bw4 and Bw6 determinants. In this study, amino acid substitutions at positions 77, as well as at positions 80-83, are shown tO contribute to the serologically defined Bw4 and Bw6 specificities and to correlate with reactivity patterns of monoclonal antibodies and alloantisera revealing heterogeneity and different epitopes of these antigens. As has been shown for other serologically highly cross-reactive subtypes of HLA antigens, HLA-B38 and -B39 are very similar in their amino acid sequences, revealing only six amino acid differences within a limited region of high polymorphism in the c~l domain. When compared with other defined HLA molecules ), B39 and B38 reveal unique sequences only in the c~2 domain. According to the X-ray crystallographic structure of HLA-A2, the specific positions 106 and 107 are possibly situated on a loop outside the antigen binding site, and amino acid 167 at the c~2-helical region is mos~ likely involved in peptide binding. Positions 158 and 168 probably interact with the T-cell receptor (Bjorkman et al. 1987) . The complete identity of exon 2 and shared substitutions of exon 3 indicate that HLA-B39 and -B14 could be derived from a common ancestor by a process involving intrallelic exchange events and point mutations, as has been suggested for other HLA alleles . No serological cross-reactivity between B14 and B39, with the exception for the Bw6 epitope, has been observed; thus, the corresponding allotypic reagents may preferentially be directed against epitopes located on the c~2 domain. Since HLA-B38 shares nucleotides with HLA-B58 (Ways et al. 1985) , -B51, and -B52 (Hayashi et al. 1989 ) at codons 74-83, it could have been generated in one step from B39 by a single exchange event in which for example HLA-B58, -B51, or -B52 donated another DNA segment encompassing codons 74-83. HLA-B39 which shares the entire c~l domain with HLA-B14, could thus be the older of the two genes. Alternatively, HLA-B38, -B39, and -B14 could have diverged simultaneously from a common ancestor by several steps of exchange events or point substitutions.
As the DNA segment flanked by codons 74 and 83 is the only region of the polymorphic c~l and a2 domains in which HLA-B38 and -B39 are different from each other, both subtypic epitopes, as well as the public determinants Bw4 or Bw6 on these molecules must be encoded within this area. The amino acid sequence SLRNLRG of HLA-B39 between residues 77 and 83 correlates completely with Bw6 of all other known HLA-B and -C antigens. According to the amino acid sequences, Bw6 is distinguishable from other HLA-A, -B, -C molecules only by the simultaneous presence of serine at position 77 and asparagine at position 80. In comparison, the HLA-Bw4 specificity could be related in HLA-B38 to the amino acid substitution asparagine at position 77 and the sequence IALR at residues 80-83. Similar substitutions, most likely generated by interlocus exchange processes, have already been found in the HLA-A molecules A32, and A24 carrying the Bw4 determinant (Wan et al. 1986) , and were also shown to code for Bw4 in the HLA-B58 (Ways et al. 1985) , -B51, -B52 (Hayashi et al. 1989) , and -B27.2 (Vega et al. 1986 ) molecules. The same polymorphic Bw4-related substitutions have also been observed in chimpanzees' B-locus antigens (Mayer et al. 1988 ) and therefore may predate divergence of human and chimpanzees MHC products. In other HLA-B molecules, alternative sequences between residues 79 to 83 were previously claimed to also be associated with the Bw4 determinant (Wan et al. 1986 ). Except for B44.1, these HLA-B molecules share the amino acids leucine and arginine at residues 82 and 83 with HLA-B38, but differ from Bw4-HLA-A or Bw6 § HLA-B antigens at positions 77 and 80-81. Thus, in contrast to HLA-Bw6, at least seven different patterns of the amino acid sequence between positions 77 and 83 could be related to HLABw4. Rearrangement of small elements of sequences through gene conversion or intra-allelic exchange events, of which an example could be NLR found at positions 77-79 in Bw4 and at residues 80-82 in Bw6, in addition to point mutations, most likely have been involved in the generation of amino acid sequence variation associated with these public HLA-B specificities.
Variable amino acid sequences are likely to also account for the serological differences of the HLA-Bw4 and -Bw6 specificities (MOiler et al. 1985a , Mtiller et al. 1982 , Layet et al. 1985 . The observed weak correlation coefficients of Bw4-versus Bw6-specific alloantisera and monoclonal antibodies (Arnaiz-Villena et al. 1989 ) appear to reflect the genetic variability of these public specificities. Reactivity patterns of monoclonal antibodies on transfectants or B-cell lines allow differentiation of two alloantigenic epitopes associated with Bw4 formed by the c~ helix of the ~1 domain between residues 77 and 83. One epitope which is suggested to contact the T-cell receptor according to the X-ray crystallographic structure of HLA-A2 is shared by alt Bw4 + HLA-B antigens, as well as by the HLA-A molecules A24, and A32, and is recognized by the Bw4-specific antibody T048. This epitope has also been defined by alloantisera (Kostyu et al. 1980) . Binding of TU48 most likely involves interaction, particularly with the amino acids leucine and asparagine, at residues 82 and 83 which are shared by all Bw4 + HLA-A and -B antigens. The other Bw4 epitope is only present on HLA-B molecules and is discriminated by antibodies like TU109. Reactivity of this antibody may rely on a particular protein conformation induced at the co-helical region by different amino acids at residues 77, 80, 81, and 82. This is suggested by selective binding of T~Jl09 to Bw4 + HLA-B, but not -A, molecules inspite of amino acid sequence variation, and could also explain the lack of reactivity with HLA-Bw44.1, exhibiting a specific Bw4-related amino acid sequence N, TAAR at these positions. According to the differential reactivity pattern of the antibodies SFR8-B6 and 2BC4 on transfectants, the Bw6 specificity could also include two epitopes. One is most likely recognized by the antibody SFR8-B6 directed against Bw6 + HLA-B and -C molecules, whereas the other one may be differentiated by 2BC4 selectively binding to HLA-B antigens. SFR8-B6 appears to interact predominantly with amino acid residues 80-83, whereas 2BC4 seems to react particularly with amino acids at positions 80-77. Conformational changes of the 2BC4-defined epitope in HLA-Cw3 through amino acid substitutions in the immediate neighboring positions (i. e., exchange of valine in HLA-Cw3 for glutamic acid at position 76 in HLA-B molecules) could explain lack of reactivity of 2BC4 with HLA-Cw3. Thus, both public specificities HLA-Bw4 and -Bw6 appear to be characterized by one epitope distant from amino acid segment 62-76 with greatest sequence diversity of the c~l domain, as well as by another epitope next to this area. Reactivity of the mAbs T0109 and 2BC4 indicate that the three-dimensional structure of the latter epitope may be influenced by amino acid substitutions in the region of high diversity. The subtypic epitope of HLA-B38 and -B39, which can be differentiated from the Bw4 or Bw6 specificity by specific alloantisera, is most likely formed by the amino acid exchange at position 74. It seems to be spatially distinct from the public specificities Bw4 and Bw6 in these molecules, whereas in other HLA-B antigens such as the B27 variants, overlapping of public and private epitopes, may occur, as is suggested by the reactivity pattern of specific mAbs like TM1 (Thurau et al. 1989) . Therefore, recognition of this epitope by Bw4-or Bw6-specific antisera may depend on similar conformation, but not neccessarily on identity of the amino acid sequence.
